126 related articles for article (PubMed ID: 3716823)
1. The pharmacokinetics and protein binding of disopyramide in pigs.
Pedersen LE; Hermansen K; Olesen HP; Rasmussen SN
Acta Pharmacol Toxicol (Copenh); 1986 Apr; 58(4):282-8. PubMed ID: 3716823
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of disopyramide.
Siddoway LA; Woosley RL
Clin Pharmacokinet; 1986; 11(3):214-22. PubMed ID: 3524956
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective pharmacokinetics of disopyramide enantiomers in man.
Lima JJ; Boudoulas H; Shields BJ
Drug Metab Dispos; 1985; 13(5):572-7. PubMed ID: 2865105
[TBL] [Abstract][Full Text] [Related]
4. Effect of concentration-dependent binding to plasma proteins on the pharmacokinetics and pharmacodynamics of disopyramide.
Giacomini KM; Blaschke TF
Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():42-8. PubMed ID: 6705426
[TBL] [Abstract][Full Text] [Related]
5. The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide.
Giacomini KM; Swezey SE; Turner-Tamiyasu K; Blaschke TF
J Pharmacokinet Biopharm; 1982 Feb; 10(1):1-14. PubMed ID: 7069575
[TBL] [Abstract][Full Text] [Related]
6. Influence of concentration-dependent protein binding on serum concentrations and urinary excretion of disopyramide and its metabolite following oral administration.
Haughey DB; Lima JJ
Biopharm Drug Dispos; 1983; 4(2):103-12. PubMed ID: 6882879
[TBL] [Abstract][Full Text] [Related]
7. Disopyramide pharmacokinetics and bioavailability following the simultaneous administration of disopyramide and 14C-disopyramide.
Lima JJ; Haughey DB; Leier CV
J Pharmacokinet Biopharm; 1984 Jun; 12(3):289-313. PubMed ID: 6502472
[TBL] [Abstract][Full Text] [Related]
8. The influence of protein binding on disopyramide clearance.
Bryson SM; Lawrence JR; Steele WH; Campbell BC; Elliott HL; Sumner DJ
Eur J Clin Pharmacol; 1982; 23(5):453-6. PubMed ID: 7151851
[TBL] [Abstract][Full Text] [Related]
9. Effects of the enantiomers of disopyramide and its major metabolite on the electrophysiological characteristics of the guinea-pig papillary muscle.
Vanhoutte F; Vereecke J; Carmeliet E; Verbeke N
Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):662-73. PubMed ID: 1775199
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans.
Aitio ML; Allonen H; Kanto J; Mäntylä R
Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):219-26. PubMed ID: 7095921
[TBL] [Abstract][Full Text] [Related]
11. The effects of urine pH and plasma protein binding on the renal clearance of disopyramide.
Cunningham JL; Shen DD; Shudo I; Azarnoff DL
Clin Pharmacokinet; 1977; 2(5):373-83. PubMed ID: 21054
[TBL] [Abstract][Full Text] [Related]
12. Disposition kinetics of disopyramide in human healthy volunteers described by an open three compartment model.
Bonde J; Jensen NM; Pedersen LE; Angelo HR; Rasmussen SN; Trap-Jensen J; Kampmann JP
Pharmacol Toxicol; 1989 May; 64(5):412-6. PubMed ID: 2771866
[TBL] [Abstract][Full Text] [Related]
13. Disopyramide concentrations in saliva.
Aitio ML; Virtanen R; Lammintausta R
Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):68-72. PubMed ID: 7061181
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog.
Karim A; Kook C; Novotney RL; Zagarella J; Campion J
Drug Metab Dispos; 1978; 6(3):338-45. PubMed ID: 26556
[TBL] [Abstract][Full Text] [Related]
15. The stereoselective disposition of disopyramide in the dog.
Giacomini KM; Giacomini JC; Swezey SE; Harrison DC; Nelson WL; Burke TR; Blaschke TF
J Cardiovasc Pharmacol; 1980; 2(6):825-32. PubMed ID: 6160331
[TBL] [Abstract][Full Text] [Related]
16. Displacement of disopyramide from human plasma proteins.
Pedersen LE; Bonde J
Acta Pharmacol Toxicol (Copenh); 1985 Sep; 57(3):223-6. PubMed ID: 4061102
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat.
Klotz U; Antonin KH; Bieck PR
J Pharmacol Exp Ther; 1976 Oct; 199(1):67-73. PubMed ID: 789856
[TBL] [Abstract][Full Text] [Related]
18. Disopyramide kinetics in renal impairment: determinants of interindividual variability.
Burk M; Peters U
Clin Pharmacol Ther; 1983 Sep; 34(3):331-40. PubMed ID: 6883909
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective disposition and metabolism of disopyramide in pediatric patients.
Echizen H; Takahashi H; Nakamura H; Ochiai K; Chiba K; Koike K; Ogata H; Ishizaki T
J Pharmacol Exp Ther; 1991 Dec; 259(3):953-60. PubMed ID: 1762088
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective pharmacokinetics and pharmacodynamics of disopyramide and its metabolite in rabbits.
Horikawa M; Yasumuro M; Kanno M; Hanada K; Hashiguchi M; Ogata H
J Pharm Pharmacol; 2001 Dec; 53(12):1621-8. PubMed ID: 11804392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
